Peroxisome proliferator-activated receptor gamma (PPARγ) activation and its consequences in humans
- 31 March 2001
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 120 (1-3), 9-19
- https://doi.org/10.1016/s0378-4274(01)00302-2
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Peroxisome Proliferator–Activated Receptor-γ Ligands Inhibit Nitric Oxide Synthesis in Vascular Smooth Muscle CellsHypertension, 2000
- Inhibitory Effect of a Proline-to-Alanine Substitution at Codon 12 of Peroxisome Proliferator-Activated Receptor-γ 2 on Thiazolidinedione-Induced AdipogenesisBiochemical and Biophysical Research Communications, 2000
- PPARγ Agonists Enhance Human Vascular Endothelial Adhesiveness by Increasing ICAM-1 ExpressionBiochemical and Biophysical Research Communications, 1999
- Thiazolidinediones Down-Regulate Plasminogen Activator Inhibitor Type 1 Expression in Human Vascular Endothelial Cells: A Possible Role for PPARγ in Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte DifferentiationNew England Journal of Medicine, 1998
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγScience, 1996
- Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha.Proceedings of the National Academy of Sciences, 1995
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993